| CAS No 356068-86-5 |
N-(2-(Diethylamino)ethyl)-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamidenull |
Inquiry |
| CAS No 35453-19-1 |
5-Amino-2,4,6-iodoisophthalic acidnull |
Inquiry |
| CAS No 350-03-8 |
3-acetylpyridinenull |
Inquiry |
| CAS No 3424-98-4 |
2'-DEOXY-L-THYMIDINEnull |
Inquiry |
| CAS No 34846-90-7 |
2-Propenoic acid,3-methoxy-, methyl esternull |
Inquiry |
| CAS No 3416-18-0 |
2H-Indol-2-one,1,3-dihydro-5-hydroxy-null |
Inquiry |
| CAS No 34040-64-7 |
Methyl 4-(chloromethyl)benzoatenull |
Inquiry |
| CAS No 341031-54-7 |
Sunitinib malatenull |
Inquiry |
| CAS No 34040-62-5 |
Benzoic acid,2-(chloromethyl)-, methyl esternull |
Inquiry |
| CAS No 331771-20-1 |
N-[4-[[6-Methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinazolinyl]amino]phenyl]benzamidenull |
Inquiry |
| CAS No 33483-65-7 |
trans-4-Methylcyclohexylamine hydrochloridenull |
Inquiry |
| CAS No 331-39-5 |
3,4-Dihydroxycinnamic acidnull |
Inquiry |
| CAS No 330645-87-9 |
HCTUnull |
Inquiry |
| CAS No 32955-21-8 |
Ethyl 2-aminothiazole-5-carboxylatenull |
Inquiry |
| CAS No 324763-51-1 |
3-Amino-2,2-dimethylpropionamidenull |
Inquiry |
| CAS No 327-78-6 |
4-Chloro-3-(trifluoromethyl)phenyl isocyanatenull |
Inquiry |
| CAS No 324763-39-5 |
4-[(2R)-2-(Chloromethyl)-3-methylbutyl]-1-methoxy-2-(3-methoxypropoxy)benzenenull |
Inquiry |
| CAS No 324519-68-8 |
(2S,4E)-5-Chloro-N,N-dimethyl-2-(1-methylethyl)-4-pentenamidenull |
Inquiry |
| CAS No 324519-66-6 |
4-Pentenoic acid,5-chloro-2-(1-methylethyl)-, (2S,4E)-null |
Inquiry |
| CAS No 320-51-4 |
5-amino-2-chlorobenzotrifluoridenull |
Inquiry |
| CAS No 318515-70-7 |
Carbamic acid,N-[[4-[2-[[(3-ethyl-2,5-dihydro-4-methyl-2-oxo-1H-pyrrol-1-yl)carbonyl]amino]ethyl]phenyl]sulfonyl]-,ethyl esternull |
Inquiry |
| CAS No 317374-08-6 |
2-Methyl-4-(2-methyl-benzoylamino)benzoic acidnull |
Inquiry |
| CAS No 318237-73-9 |
Imidazo[4,5-d][1]benzazepine,1,4,5,6-tetrahydro-2-methyl-null |
Inquiry |
| CAS No 31719-77-4 |
3-(Chloromethyl)benzoic acidnull |
Inquiry |
| CAS No 3113-72-2 |
5-methyl-2-nitrobenzoic acidnull |
Inquiry |
